Logo Logo

Publications by Overkamp, F.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 5.

Journal article

Stähler, M.; Göbell, P. J.; Müller, L.; Overkamp, F.; Frank, M.; Kruggel, L.; Jänicke, M.; Marschner, N. (2017): Treatment reality and outcome data of patients with advanced papillary renal cell carcinoma - data from the German prospective RCC-Registry. In: Oncology Research and Treatment, Vol. 40: p. 96

Stähler, M.; Müller, L.; Göbell, P. J.; Overkamp, F.; Frank, M.; Kruggel, L.; Jänicke, M.; Marschner, N. (2017): Treatment reality and outcome data of patients with advanced papillary renal cell carcinoma: Data from the German prospective RCC-Registry. In: Annals of Oncology, Vol. 28

Untch, M.; Augustin, D.; Ettl, J.; Haidinger, R.; Harbeck, N.; Lück, H.-J.; Lüftner, D.; Marée, F.; Müller, L.; Overkamp, F.; Ruckhäberle, E.; Thill, M.; Thomssen, C.; Wuerstlein, R.; Marschner, N. (2016): ABC3 Consensus Commented from the Perspective of the German Guidelines Third International Consensus Conference for Advanced Breast Cancer (ABC3), Lisbon, 07.11.2015. In: Geburtshilfe und Frauenheilkunde, Vol. 76, No. 2: pp. 156-163

Janning, M.; Müller, V; Vettorazzi, E.; Cubas-Cordova, M.; Gensch, V; Ben Batalla, I; Eulenburg, C. zu; Schem, C.; Fasching, P. A.; Schnappauf, B.; Karn, T.; Fehm, T.; Just, M.; Kühn, T.; Holms, F.; Overkamp, F.; Krabisch, P.; Rack, B.; Denkert, C.; Untch, M.; Tesch, H.; Rezai, M.; Kittel, K.; Pantel, K.; Bokemeyer, C.; Loibl, S.; Minckwitz, G. von; Loges, S. (2016): Serum carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: a biomarker analysis from the GeparQuinto phase III neoadjuvant breast cancer trial. In: Oncology Research and Treatment, Vol. 39: p. 185

Schinköthe, T.; Harbeck, N.; Overkamp, F.; Weislau, M.; Würstlein, R.; Gieseler, F. (2016): CANKADO: First open eHealth platform for Oncology. In: Oncology Research and Treatment, Vol. 39: p. 23

This list was generated on Mon Oct 18 13:39:36 2021 CEST.